Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 10.60p 10.20p 11.00p 10.60p 10.60p 10.60p 0 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 2.8 -0.5 -0.2 - 21.96

Eden Research Share Discussion Threads

Showing 6976 to 6998 of 7350 messages
Chat Pages: Latest  282  281  280  279  278  277  276  275  274  273  272  271  Older
DateSubjectAuthorDiscuss
07/5/2019
15:54
I really hope all this is going on in the background as sometimes it's very hard to detect anything going on at all..
bjlk
07/5/2019
15:21
Brucie...If I am anywhere near right, Bayer might be very interested in partnering with the head lice product (but I am not saying it's them yet!) and possibly also be very interested in other products and in particular Eden's novel encapsualtion and delivery platform, Sustaine. What I am also suggesting, is that Bayer can effectively lock Eden's AH products out of the US (by stalling or even requiring further formulation work!)......however, that agreement was based on an earlier (but still effective) encapsulation technology, so it's possible that the exclusivity previously agreed with Bayer may 'not' prevent Eden agreeing to launch with another party using the latest generation of encapsulation technology. I believe the strength of Eden's intellectual property portfolio is already evident in terms of their existing partners involvement and investments, not to mention that those partners have their own 'extensive' patent portfolio's and expertise. Regulatory approvals will further cement that strength and further strengthen Eden's negotiating hand, not to mention strengthen the share price, hence we need to maintain our patience. To quote from my title post - "In order to fully and effectively exploit the inherent advantages of these new and less stable products, new formulation, stabilization and delivery technologies will be required. Thus, a very large opportunity is presenting itself, and if Eden's delivery technologies could address only a small percentage of this market, it would transform the company!" The Chairman has clearly recognised the potential in Sustain (and he should know), and with momentum building in terms of product authorisation and validation, along with new interest, a couple of AH products not being launched will neither break the bank, nor stop Sustaine ultimately becoming a success. So, it's also possible that Eden itself may be playing hard ball, but for all the right reasons and a strengthening hand!
wan
07/5/2019
15:04
fyi..SEE is stirring.
supersonico
07/5/2019
14:18
Wan, should have said Thanks for the links and digging around. Good job
brucie5
07/5/2019
14:18
Wan, should have said Thanks for the links and digging around. Good job
brucie5
07/5/2019
12:35
Ok, so to be crystal clear, you surmise that Bayer are the crypto-partner for TT as well as the stated partner for CAP; and that they are unhappy to be out of the loop for Sustaine, so using the CAP/TT delays as a way of advancing their negotiating hand with whatever is progressing behind closed doors at Sustaine, in which, we presume, they have a seat at the table. (Why would they not?) Sorry to be so plain. But I think that's what you're saying?
brucie5
07/5/2019
11:25
Brucie...Call it what you will, an impasse perhaps, but to my mind there appears to be a connection between the head lice delays and the AH product delays. I am only guessing at what appears, on the face of it, to be coincidental, but I am not buying into coincidental. The routine delays are a trend, clearly a trend is not a coincidence. Given that Eden has already revealed that there is increased interest in Sustain (other than from Sipcam), it's not out of the realms of possibility that Bayer would like far more than the AH products. So, it's also not out of the realms of possibility that the launch of the AH products are forming part of the negotiations. If Sustaine can also be a delivery platform on seeds (obviously it can do a lot more, but I think it could be applicable to seeds), then that aspect alone would be of great interest to Bayer - 3rd May 2019 Biological seed treatments have become an increasing important aspect of sustainable agriculture.In partnership with global leaders in biological solutions like Novozymes, Bayer SeedGrowth is at the forefront of biologicals development, expected to be one of the fastest growing seed treatment sectors in the near future. Full story - hTTp://news.agropages.com/News/NewsDetail---30331.htm 19th January 2019 Read how Martin Gruss, former Global Head Bayer SeedGrowth, will now hand over the business to his successor Boualem Saidi – and why the ambition of Bayer is clearly to strengthen its leading role in seed-applied technologies. Excerpt - Furthermore, we’d like to strengthen existing partnerships and build new ones, and accelerate alliances and co-operations. We’ll be present at leading industry events such as the ISF World Seed Congress and the European Seed Association (ESA) Annual Meeting, where we will exchange knowledge and establish dialogue with all key players along the value chain. Full interview - hTTps://www.seedgrowth.bayer.com/cases/the_new_setup_for_growth?id=%7B110AA661-CC0C-4A46-A117-CB9B9508ED2B%7D As the validation of Sustaine gathers momentum, the existing and new interest will have to break cover.......in one form or another!
wan
07/5/2019
10:08
There goes another one..news EU ban on chlorothalonil endorsed by member states hTTp://news.agropages.com/News/NewsDetail---29963.htm ……………………………… (Surprising to Reeves the Baker Pasty Lovers) The Conservation of Native Honey Bees Is Crucial hTTps://www.cell.com/trends/ecology-evolution/fulltext/S0169-5347(19)30117-X
supersonico
07/5/2019
09:27
Wan, Sorry to be thick: Bayer 'playing hard ball' in what sense? You're suggesting these are deliberate delays, used as bargaining chips. To what end?
brucie5
07/5/2019
09:27
Wan, Sorry to be thick: Bayer 'playing hard ball' in what sense? You're suggesting these are deliberate delays, used as bargaining chips. To what end?
brucie5
07/5/2019
08:28
Brucie...I continue to not hold my breath with regard to Bayer! Strictly in my opinion only, if we do not get further evidence/announcement in the interim, the impending launch of head lice product in September might be instructive! Clearly the CEO did not sign the original deal with Bayer, but he is stuck with it and Bayer has exclusivity......however, in terms of the animal health products, Eden's next-generation encapsulation technology might enable Eden to move on with another partner/distributor, or maybe it could get Bayer moving forward 'proper' on the animal health products.....or even agreeing to a much wider deal! As it stands though, my preference is with those partners that have 'effectively' demonstrated that they have got on with the job, Sipcam and Eastman. Sustaine is almost certainly of interest beyond Sipcam and Eastman (Eden has said as much) and validation of Sustaine is gaining momentum (and escape velocity from Bayer?). So, if Bayer are playing hard ball (which is my 'guess'), then they might have a harder fight on their hands than they envisaged/bargained for!
wan
06/5/2019
18:29
Good points, chrischas. My assumption is that well established partners on the ground are doing the door to door. Hence Mevalone sales this far, and Cedroz early doors emergency clearance in Italy.
brucie5
06/5/2019
17:04
Pesticides, poisoning and the politics of agrichemicals between Europe and Brazil Brazil is one of the most important suppliers of foods, grains and biofuels to the European market. European firms are among those behind the record levels of hazardous use of pesticides in Brazil, despite many of these chemicals being prohibited in the EU. In 2016 alone Brazil registered 4,208 cases of intoxication by exposure to pesticides and 355 deaths by agricultural chemicals. Amidst weakening regulation in both EU and Brazil, the work of Larissa Mies Bombardi maps the illness, death and infant malformation in Brazil in relation to these toxins, and outlines the risk of contamination of foods being consumed in both Brazil and Europe. We welcome you to join her and leading researchers in pesticide regulation, food contamination and labour standards to explore the contradictions in trade regulations, the power of corporate lobbies, and how civil society can better understand and tackle policy and politics behind agrochemical pollution and poisoning. Co-ordinated by Work, Labour and Globalisation network at University of Strathclyde, European Network of Scientists for Social and Environmental Responsibility and Pesticide Action Network Europe. hTTps://ensser.org/events/2019/pesticides-poisoning-and-the-politics-of-agrichemicals-between-europe-and-brazil/
supersonico
06/5/2019
16:56
Italian Direction of Travel ..news Phytosanitary defense, regulatory updates hTTps://agronotizie.imagelinenetwork.com/difesa-e-diserbo/2019/05/06/difesa-fitosanitaria-aggiornamenti-normativi/62861?fbclid=IwAR3-ewxCeQlX7iQlV4AVOcIzpYMk9jZK8lngzTGKMUDFF-MAaPEo7BPfe7s The day of study scheduled for June 26 in Bologna is scheduled for Aipp Phytopathological Days on "Regulatory updates on phytosanitary defense", which will be held at 10.00 am in the Aula Magna of the Department of Agricultural and Food Sciences, Distal, in Viale Giuseppe Fanin, 44/46. In order to increase the security guarantees for man, biodiversity and the environment the rules that regulate the authorization and use of technical means for phytosanitary defense have been profoundly modified in recent years and are subject to continuous updating. The meeting will inform the operators of the phytoiatric sector, thanks to the intervention of Italian experts, on the foreseeable next regulatory evolution concerning some relevant aspects of the management of plant protection products and defense at national and European level. Program Maristella Rubbiani of the Higher Institute of Health will present the evaluation criteria for endocrine disruptors, while Sara Villa of the Milano Bicocca University will present the new guideline for bee evaluation and impact on ecotoxicological risk management. Focus then on the "National action plan for the sustainable use of plant protection products (Pan) 2019-2023: the main innovations contained in the draft in consultation" with Pasquale Falzarano of the Ministry of Agricultural, Food, Forestry and Tourism Policies - DG Development Rural, Disr III Office - Agriculture, Environment and Farm Holidays and Floriano Mazzini of the Phytosanitary Service, Emilia-Romagna Region. Finally, we will analyze the less well-known technical means of defense: basic and corroborating substances with Giorgio Zena of Ibma Italia. The discussion and conclusions of the meeting will follow. To participate in the meeting registration is required by filling in the online form available starting from Monday 13 May on the site of the Phytopathological Days Phytopathological Days Secretariat: Department of Food Science and Technology, Università degli Studi, Viale G. Fanin, 40/42 - 40127 Bologna Tel 051.2096546 / 2096566 E-mail: 'sameage
supersonico
06/5/2019
16:52
Helpful, thanks.
brucie5
06/5/2019
15:46
Just googled the 60 harvest thing. I hadn't seen this before. Presumably, the biggest pesticidal adversary is glyphosate via roundup, on account of its current scale, and its impact on soil, worms and microbes Has Eden got an answer to this one? Corn, soy, hay and wheat being the largest legal cash crops in the USA. A lot of which goes to feed cattle. And mix with petrol to make biofuels, ironically
brucie5
06/5/2019
15:32
Scandi Noir is a drama that you need to have followed. It cannot be explained :) The Industry was and still is so full of arrogance and Hubris but Glyphosate, Autism and catastrophic ecological collapse, 60 harvest Doom, the growth of Resistant fungi/bacteria are all helping shift the paradigm and conversation rapidly. Indicators.. Regulatory pressure on many Conventional pesticides. Significant Organic market and Biopesticide market growth. Emergency Cedroz derogation along with EGTOP changes and Derogations in organic inputs as market demand outstrips supply. My view is that significant investors are coming on board quietly and their is likely to be further strategic investment this year. That would make sense to me.
supersonico
06/5/2019
14:58
Some talk of hope triumphing over experience. Which will be proved right in this case. ? Unfortunately, I'm here to tell you that servicing an eco critical industry is no guarantor or success, nor is having excellent technology. Michael Walters' site is full of such stories, most of which never saw the light. I am hopeful here, as my investment evidences: but also extremely wary. Lykele, for one, has yet to make his maiden investment. Secondly, the bod appear to own a lot less in paid up shares than any racing certainty would suggest they might. Thirdly, when a share is truly ready to restate, as jlp is currently doing, you see significant investors coming on board. Just sayin'. Please explain relevance of scandi noir. Sometimes you are more recondite than a play by Samuel Beckett. And this feels a lot like waiting for Godot.
brucie5
06/5/2019
14:35
What imo the market is missing is the reason or context as to why Eden keeps not delivering with TT and Bayer etal and potential the crop protection vertical offers. The market looks at the delays as failure to deliver despite the current climate and ecological emergency we now face. I look at these delays as the industry catching up with the potential Eden's Tech has in the stark reality of the death of Green revolution ecocidal Chemistry . Once they became aligned the opportunities amplify, NDA'S restrict communication and the delays caused by bigger plans/strategies/alliances become wider, and more valuable but look to the market like non performance and a little incompetent to boot. But that's just the Noise above the transformational change the technology truly offers. The Market has not got a clue and whilst it is myopic, Investors and Film buffs like us, early to the feast get a decent portion for our hard earned. Hopefully.
supersonico
06/5/2019
14:17
Atty, a while ago you said you had dreams of a share price in the several pounds. Do you still hold this, and if so, are you able to illustrate?
brucie5
06/5/2019
14:12
Super, Quite right, we know, the market doesn't so very, very frustrating. AttyG, We have been under promising for several years now and as Super points out, the market just needs to catch up their understanding with the likes of us who are more fervent. All I ask is that Eden conveys our understanding, their understanding, more thoroughly so value is understood, not misunderstood, not undervalued and equally not hyped. Just plain simple communications demonstrating true current value. Some of us might argue that Shore Capital is misleading the market by downplaying or not understanding Eden and its value correctly. Eden could of course, correct that.
investingisatrickygame
06/5/2019
14:02
Well it’s going to be really interesting in late September/Oct if the hard working partners have had any meaningful sales figures.If they have it will be all down to the absolute change in the market that has occurred and is occurring.They certainly will have to do it by themselves.
chrischas
06/5/2019
13:44
Agreed super. My view (and possibly Sean's view too) is that, for various reasons, we did not deliver what was indicated to the market and consequently the market pays little heed to the words from Sean and Lykele. So, till,we post numbers that demonstrate the story is truly now becoming reality, the share price will not reflect the soon to be realised potential. Thus Sean downplays the story? Under promise over deliver?
attyg
Chat Pages: Latest  282  281  280  279  278  277  276  275  274  273  272  271  Older
Your Recent History
LSE
EDEN
Eden Resea..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190618 12:43:27